(Q36485259)

14 August 2017

1 reference

title

Post-genomic vaccine development (English)

1 reference

14 August 2017

2

Rino Rappuoli

1 reference

14 August 2017

1

Davide Serruto

1 reference

PubMed ID

16716781

14 August 2017

language of work or name

English

0 references

publication date

4 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

580

1 reference

14 August 2017

12

1 reference

14 August 2017

2985-2992

1 reference

Whole-genome random sequencing and assembly of Haemophilus influenzae Rd

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Application of microbial genomic science to advanced therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Accurate multiplex polony sequencing of an evolved bacterial genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Bacterial genomics and pathogen evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Meningococcal disease: how to prevent and how to manage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome"

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

21 January 2018

The microbial pan-genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Identification of a universal Group B streptococcus vaccine by multiple genome screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Identification of group B streptococcal Sip protein, which elicits cross-protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

A pneumococcal pilus influences virulence and host inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Using DNA microarrays to study host-microbe interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Microarray analysis of bacterial pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Microarray expression profiling: capturing a genome-wide portrait of the transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Chips with everything: DNA microarrays in infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Pushing the limits of cellular microbiology: microarrays to study bacteria-host cell intimate contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Proteomics to study genes and genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Antibacterial vaccine design using genomics and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Whither structural biology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

The rational design of an AIDS vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

The TB structural genomics consortium: providing a structural foundation for drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

High-throughput crystallography at an affordable cost: the TB Structural Genomics Consortium Crystallization Facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Mycobacterium tuberculosis: a model system for structural genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

A macrophage invasion mechanism of pathogenic mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Genome of the Bacterium Streptococcus pneumoniae Strain R6

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Identification of major outer surface proteins of Streptococcus agalactiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Multilocus analysis of extracellular putative virulence proteins made by group A Streptococcus: population genetics, human serologic response, and gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Postgenomic analysis of four novel antigens of group a streptococcus: growth phase-dependent gene transcription and human serologic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Genomic approach for analysis of surface proteins in Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Parasitology. Malaria--from infants to genomics to vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Plasmodium post-genomics: better the bug you know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

Genome Analysis Reveals Pili in Group B Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.04.084

10.1016/J.FEBSLET.2006.04.084

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16716781